Page last updated: 2024-10-24

cefuroxime and Aortic Valve Insufficiency

cefuroxime has been researched along with Aortic Valve Insufficiency in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).

Research Excerpts

ExcerptRelevanceReference
" The Ministry of Health has recently alerted practitioners to the possible risk of heart valve damage following the long-term use of weight-loss drugs fenfluramine (Ponderax) and dexfenfluramine (Adifax)."1.30Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation. ( Ellis-Pegler, RB; Hay, KD; Lang, SD; Neutze, JM; Swinburn, BA, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singal, A1
Malani, PN1
Day, LJ1
Pagani, FD1
Clark, NM1
Ellis-Pegler, RB1
Hay, KD1
Lang, SD1
Neutze, JM1
Swinburn, BA1

Other Studies

2 other studies available for cefuroxime and Aortic Valve Insufficiency

ArticleYear
Roseomonas infection associated with a left ventricular assist device.
    Infection control and hospital epidemiology, 2003, Volume: 24, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; Aortic Valve Insufficiency; Cardiomyopathies; Cefuroxime; Cross I

2003
Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation.
    The New Zealand dental journal, 1999, Volume: 95, Issue:421

    Topics: Adult; Anti-Obesity Agents; Antibiotic Prophylaxis; Aortic Valve Insufficiency; Cefuroxime; Cephalos

1999